Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients
Open Access
- 24 February 2022
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
- Vol. 39 (1), 1-12
- https://doi.org/10.4274/tjh.galenos.2021.2021.0326
Abstract
Objective: Based on the immunophenotype, acute lymphoblastic leukemia (ALL) can be categorized into B-cell or T-cell lineages. B-cell precursor ALL (BCP-ALL) cases show various genetic/molecular abnormalities, and varying frequencies of chimeric fusion transcripts in BCP-ALL cases are reported from different parts of the world. We studied the immunophenotypic aberrancy profiles of a large number of BCP-ALL cases with respect to various common chimeric fusion transcripts. Materials and Methods: Flow cytometric immunophenotyping and multiplex reverse-transcription polymerase chain reaction assays were performed for 986 BCP-ALL cases. Results: Among 986 BCP-ALL cases, the incidence of various fusion transcripts was 38.36% in adult cases and 20.68% in pediatric cases. Adult BCP-ALL patients with t(9;22)(BCR-ABL1) fusion transcripts and expression of aberrant myeloid markers were significantly older at presentation (p=0.0218) with male preponderance (p=0.0246) compared to those without aberrant myeloid expression. In pediatric patients with the t(12;21)(ETV6-RUNX1) chimeric fusion transcript, aberrant expression of CD13 was observed in 39.13%, CD33 in 36.95%, and CD117 in 8.69% of patients, respectively. Pediatric BCPALL patients with the ETV6-RUNX1 fusion transcript and expression of aberrant myeloid markers were not significantly different compared to those without with respect to demographic and clinical/hematological characteristics (p=0.5955). Aberrant myeloid markers were rarely or never expressed in pediatric and adult BCP-ALL patients with the t(4;11)(KTM2A-AF4) and t(1;19)(TCF3-PBX1) fusion transcripts. Conclusion: Aberrant myeloid markers were frequently expressed among BCP-ALL patients with the t(9;22)(BCR-ABL1) and t(12;21) (ETV6-RUNX1) fusion transcripts. However, BCP-ALL patients with the t(4;11)(KTM2A-AF4) and t(1;19)(TCF3-PBX1) fusion transcripts rarely or never expressed aberrant myeloid markers. Aberrant myeloid CD markers can be used in predicting chimeric fusion transcripts at baseline so as to plan appropriate tyrosine kinase inhibitor therapy in cases of BCP-ALL with specific chimeric fusion transcripts. This study has delineated the relationship of chimeric fusion transcripts with the aberrant expression of myeloid markers in a large cohort of BCP-ALL cases.Keywords
This publication has 30 references indexed in Scilit:
- Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 ProtocolJournal of Oncology, 2012
- Incidence of Common Chimeric Fusion Transcripts in B-Cell Acute Lymphoblastic Leukemia: An Indian PerspectiveActa Haematologica, 2012
- Adolescents and Young Adults with Acute Lymphoblastic LeukemiaHematology, 2010
- Prognostic Significance of TEL/AML1 Rearrangement and Its Additional Genetic Changes in Korean Childhood Precursor B-Acute Lymphoblastic LeukemiaAnnals of Laboratory Medicine, 2010
- Characterization of Immunophenotypic Aberrancies in 200 Cases of B Acute Lymphoblastic LeukemiaAmerican Journal of Clinical Pathology, 2009
- Immunophenotypic profile of acute leukemia: Critical analysis and insights gained at a tertiary care center in IndiaCytometry Part B: Clinical Cytometry, 2008
- Simple multiplex RT‐PCR for identifying common fusion transcripts in childhood acute leukemiaInternational Journal of Laboratory Hematology, 2008
- Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the WestLeukemia, 2003
- Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistanceBritish Journal of Haematology, 1999
- Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech RepublicLeukemia, 1998